Bando Chemical Industries, Ltd.
【Bando Chemical】 Fiscal Year Ending March 2026 Financial Results | Sales of 119,257 million yen (+3.2%)
Bando Chemical's consolidated sales for the fiscal year ending March 2026 are 119,257 million yen, a 3.2% increase from the previous fiscal year. Net income rose by 264.2% to 10,568 million yen, and earnings per share increased to 256.49 yen.
Key Figures
- Sales Revenue: 119,257 million yen (YoY +3.2%)
- Net Income Attributable to Owners of Parent: 10,568 million yen (YoY +264.2%)
- Earnings Per Share for the Period: 256.49 yen (YoY +220.17 yen)
AI要約
Financial Highlights
Bando Chemical's consolidated sales for the fiscal year ending March 2026 reached 119,257 million yen, representing a 3.2% increase from the previous year. Net income surged by 264.2% to 10,568 million yen, with earnings per share rising to 256.49 yen. Operating income and pre-tax income also increased, notably driven by insurance claim receipts and deferred tax asset recognition.
Future Outlook and Investor Implications
This earnings report features significant net income growth driven by insurance claim receipts and tax asset increases. Moving forward, the company aims to maintain a stable earnings base while focusing on business strategy execution and risk management. Investors should pay attention to the sustainability of growth factors and future strategic initiatives.
Bando Chemical Industries Ltd.
Company overview · Stock price · Financial data · All IR
